中證網訊 萬(wan)孚生物(300482)4月27日晚(wan)間公(gong)布2017年(nian)(nian)年(nian)(nian)度報告,報告期(qi)內,公(gong)司實(shi)現營業總收入114,548.44萬(wan)元,比上(shang)(shang)年(nian)(nian)同(tong)期(qi)增(zeng)長109.28%;營業總成本91,945.82萬(wan)元,比上(shang)(shang)年(nian)(nian)同(tong)期(qi)增(zeng)長130.49%;歸屬(shu)于(yu)上(shang)(shang)市(shi)公(gong)司股(gu)東(dong)的凈(jing)利(li)潤(run)(run)21,069.50萬(wan)元,比上(shang)(shang)年(nian)(nian)同(tong)期(qi)增(zeng)長45.32%;歸屬(shu)于(yu)上(shang)(shang)市(shi)公(gong)司股(gu)東(dong)的扣除非(fei)經常性損(sun)益后的凈(jing)利(li)潤(run)(run)17,939.18萬(wan)元,比上(shang)(shang)年(nian)(nian)同(tong)期(qi)增(zeng)長45.83%,擬向(xiang)(xiang)全體股(gu)東(dong)每10股(gu)派(pai)發現金紅利(li)5元(含稅),以資本公(gong)積金向(xiang)(xiang)全體股(gu)東(dong)每10股(gu)轉增(zeng)8股(gu)。(沈楠(nan))